These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21519239)

  • 1. Red blood cells from induced pluripotent stem cells: hurdles and developments.
    Mazurier C; Douay L; Lapillonne H
    Curr Opin Hematol; 2011 Jul; 18(4):249-53. PubMed ID: 21519239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Red blood cell production for transfusion purposes. A stem cell ex vivo fate].
    Mazurier C; Douay L
    Transfus Clin Biol; 2013 May; 20(2):90-4. PubMed ID: 23601197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo production of human red blood cells from hematopoietic stem cells: what is the future in transfusion?
    Douay L; Andreu G
    Transfus Med Rev; 2007 Apr; 21(2):91-100. PubMed ID: 17397760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.
    Takenaka C; Nishishita N; Takada N; Jakt LM; Kawamata S
    Exp Hematol; 2010 Feb; 38(2):154-62. PubMed ID: 19922768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells: will they be safe?
    Jalving M; Schepers H
    Curr Opin Mol Ther; 2009 Aug; 11(4):383-93. PubMed ID: 19649983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges.
    Peyrard T; Bardiaux L; Krause C; Kobari L; Lapillonne H; Andreu G; Douay L
    Transfus Med Rev; 2011 Jul; 25(3):206-16. PubMed ID: 21377319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced human pluripotent stem cells: promises and open questions.
    Rolletschek A; Wobus AM
    Biol Chem; 2009 Sep; 390(9):845-9. PubMed ID: 19558327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells.
    Baek EJ; Kim HS; Kim S; Jin H; Choi TY; Kim HO
    Transfusion; 2008 Oct; 48(10):2235-45. PubMed ID: 18673341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From stem cells to red blood cells: how far away from the clinical application?
    Xie X; Li Y; Pei X
    Sci China Life Sci; 2014 Jun; 57(6):581-5. PubMed ID: 24829108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of human induced pluripotent stem cells.
    Ohnuki M; Takahashi K; Yamanaka S
    Curr Protoc Stem Cell Biol; 2009 Jun; Chapter 4():Unit 4A.2. PubMed ID: 19536759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The promise of human induced pluripotent stem cells for research and therapy.
    Nishikawa S; Goldstein RA; Nierras CR
    Nat Rev Mol Cell Biol; 2008 Sep; 9(9):725-9. PubMed ID: 18698329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro production of red blood cells.
    Mountford JC; Turner M
    Transfus Apher Sci; 2011 Aug; 45(1):85-9. PubMed ID: 21723197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for the manufacture of red cells for transfusion.
    Mountford J; Olivier E; Turner M
    Br J Haematol; 2010 Apr; 149(1):22-34. PubMed ID: 20151974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of pluripotency in human cord blood unrestricted somatic stem cells.
    Zaehres H; Kögler G; Arauzo-Bravo MJ; Bleidissel M; Santourlidis S; Weinhold S; Greber B; Kim JB; Buchheiser A; Liedtke S; Eilken HM; Graffmann N; Zhao X; Meyer J; Reinhardt P; Burr B; Waclawczyk S; Ortmeier C; Uhrberg M; Schöler HR; Cantz T; Wernet P
    Exp Hematol; 2010 Sep; 38(9):809-18, 818.e1-2. PubMed ID: 20541586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies toward CNS-regeneration using induced pluripotent stem cells.
    Okano H
    Genome Inform; 2009 Oct; 23(1):217-20. PubMed ID: 20180278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
    Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
    Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance.
    Lei F; Zhao B; Haque R; Xiong X; Budgeon L; Christensen ND; Wu Y; Song J
    Cancer Res; 2011 Jul; 71(14):4742-7. PubMed ID: 21628492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of human induced pluripotent stem cells from a Bombay individual: moving towards "universal-donor" red blood cells.
    Seifinejad A; Taei A; Totonchi M; Vazirinasab H; Hassani SN; Aghdami N; Shahbazi E; Yazdi RS; Salekdeh GH; Baharvand H
    Biochem Biophys Res Commun; 2010 Jan; 391(1):329-34. PubMed ID: 19912985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of murine embryonic stem and induced pluripotent stem cells to renal lineage in vitro.
    Morizane R; Monkawa T; Itoh H
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1334-9. PubMed ID: 19883625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.